Perleux

Perleux is a stabilized, BDDE-free injectable hyaluronic acid (HA) dermal filler developed by the Iranian company Espad Pharmed. It is formulated as a buffered physiological solution containing a hybrid of high molecular weight (H-HA) and low molecular weight (L-HA) hyaluronic acid, with a concentration of 16 mg of each per 1 mL. The product is designed for aesthetic and cosmetic use, including soft-tissue augmentation, wrinkle correction, and facial volumization. Its mechanism of action involves physical tissue augmentation through the intrinsic capacity of hyaluronic acid to bind large amounts of water, thereby restoring moisture, improving skin tone and texture, and treating skin laxity. Perleux is typically administered via intradermal, dermal, or subcutaneous injection into facial bioaesthetic points.

Brand names

Perleux